The group consists of 265,438+00 companies including Sichuan Jindi Chinese Herbal Medicine Planting Group Co., Ltd., Sichuan Kechuang Pharmaceutical Group Co., Ltd., Kechuang Pharmacy Chain Company, Hong Kong Pacific Hotel Group Co., Ltd., Chengdu Pacific Real Estate Group Co., Ltd., Admiralty Construction Group Co., Ltd. and Sichuan Venture Capital Guarantee Co., Ltd. ..
The subordinate enterprises of the Group have been rated as "honest enterprise", "law-abiding honest unit", "big taxpayer", "AAA" credit enterprise and "AAA" customer satisfaction enterprise by governments at all levels over the years. The Group has successively won the Brand China Innovation Award in 20 1 0/year, the medical and health industry leader in China in 201year, the top ten growth of China's medical and health industry in 201year, the model collective of national unity and progress in Sichuan Province and China. Tongxin Chuanshang Guangcai Caring for Disabled Enterprises, National Advanced Private Enterprises in Employment and Social Security, Award for Social Welfare Contribution of Private Enterprises, National Advanced Unit in Ideological and Political Work of Private Enterprises, National Advanced Collective in Earthquake Relief, National Advanced Model of Non-public Economy, Chengdu Model Enterprise in Harmonious Labor Relations, and Chengdu Demonstration Site for Party Workers in Non-public Economic Organizations to Strive for Excellence.
In the pharmaceutical manufacturing industry, a complete pharmaceutical industrial chain has been formed, which integrates medicinal material cultivation, pharmaceutical production, new drug research and development, pharmaceutical sales and pharmaceutical chain. Among them, there are more than 80 Chinese herbal medicine planting companies, and more than 50 authentic Chinese herbal medicine planting bases have been established in 2 1 prefecture, city and state of the province, with a planting area of over 6,543,800 mu. Adopt the model of "company+base+professional association+farmers" to drive farmers to get rich. In terms of pharmaceutical manufacturing, there are more than 30 pharmaceutical manufacturers certified by the national GMP, which can produce more than 500 varieties of Chinese patent medicines, chemicals, Tibetan medicines, biological medicines and health foods in 10 dosage forms. With glucomannan capsules, children's Ding Feng pills and other 10 national exclusive varieties, Li Qiang Tianma eucommia capsule, Qingnao Shen Fu liquid and other dozens of national key protected varieties. In terms of pharmaceutical trade, there are more than 100 pharmaceutical companies and 1000 chain pharmacies in China, and the drug sales network covers more than 300 large, medium and small cities in China, and has established long-term and stable cooperative relations with more than 5,000 large and medium-sized hospitals and distributors, realizing the marketing model of first-class distribution and second-class coverage of drugs.
In terms of engineering construction and real estate industry, the Group covers all businesses such as development, design, construction, decoration, supervision, property management and building materials, and has launched commercial, industrial and commercial projects with an area of over 3 million square meters.
In terms of hotel service industry, the Group owns five hotels, including five-star hotels and four-star hotels. The hotel group is headquartered in Hong Kong.
There are guarantee companies, banks, small loans, audit firms, evaluation firms, law firms, land auctions and other companies in the financial industry.
In the intermediary consulting industry, there are human resources companies, investment consulting companies, labor service companies, colleges and so on.
Scientific research strength
The Group has long-term strategic cooperative relations with China Academy of Military Medical Sciences, West China College of Pharmacy of Sichuan University, Chengdu University of Traditional Chinese Medicine, Jiangxi College of Traditional Chinese Medicine, Sichuan Institute of Traditional Chinese Medicine, Chongqing Institute of Traditional Chinese Medicine and China Academy of Tropical Agricultural Sciences. , and conducted in-depth research and development on modern drugs, health food and food.
The "polypeptide drug research and development production base" jointly established with China Academy of Military Medical Sciences will become the largest third-generation polypeptide drug research and development production base in China.
Pharmaceutical Group has obtained the clinical approval of SFDA, Xiaoyu Anshen Capsule and other new drugs and a number of national invention patents, which have been included in the national "Eleventh Five-Year Plan" and "Twelfth Five-Year Plan" major new drug creation projects.
Many research achievements of pharmaceutical group have won national and provincial scientific and technological achievement awards. Strong scientific research strength has laid a solid foundation for the rapid development of Kechuang Pharmaceutical Group.